Diagnostic Medical Systems S.A. (ALDMS.PA) Valuation

Valuation

Model-based estimates, not advice. The DCF is the discounted-cash-flow value per share; compare it with the price, not as a target.

DCF fair value

-761.8%

-€6.02

vs €0.91 price

Levered DCF

-€5.14

After debt service

Piotroski score

4 / 9

Average

Altman Z-score

1.73

Distress zone

Rating

C+

Overall 2 / 5

Ratios by fiscal year

Margins and yields are shares of revenue, equity or price; multiples are ×.

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
P/E	-186.76×	-4.69×	-2.04×	-2.4×	-5.08×	-5.5×	-6.47×	-2.13×
P/B	1.77×	1.06×	1.61×	1.04×	1.05×	1.66×	1.35×	0.64×
P/S	0.68×	0.29×	0.45×	0.46×	0.54×	0.88×	0.64×	0.47×
EV / EBITDA	10.8×	-53.72×	40.24×	-9.24×	-86.08×	-228.05×	-28.78×	-5.23×
Gross margin	3.3%	39.9%	36.3%	39.2%	38.3%	39.3%	27.7%	27.5%
Operating margin	3.7%	-0.8%	-5.1%	-16.7%	-2.3%	-10.5%	-14.3%	-21.4%
Net margin	-0.3%	-6.3%	-11.2%	-19.3%	-10.7%	-16.3%	-10.4%	-22.4%
Current ratio	1.37×	1.29×	1.44×	1.19×	1.29×	1.35×	1.09×	1.5×
Debt / equity	0.98×	1.56×	1.62×	0.98×	0.85×	0.87×	0.67×	0.37×
Interest coverage	1.68×	-0.15×	-4.97×	-26.11×	-2.18×	-3.6×	-25.36×	-65.75×
Dividend yield	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%
Payout ratio	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Key metrics by fiscal year

Metric	FY2025	FY2024	FY2023	FY2022	FY2021	FY2020	FY2019	FY2018
Return on equity	-0.9%	-22.4%	-39.9%	-43.5%	-20.7%	-30.6%	-22.1%	-30.2%
Return on invested capital	1.7%	-0.9%	-6.3%	-24.0%	-2.4%	-10.4%	-17.6%	-20.6%
Return on assets	-0.3%	-5.3%	-9.7%	-12.7%	-7.3%	-11.4%	-8.0%	-14.8%
Free cash flow yield	-9.4%	0.2%	-21.9%	-10.0%	-35.4%	-23.9%	-15.2%	-34.5%
Earnings yield	-0.5%	-21.2%	-24.8%	-41.9%	-19.7%	-18.5%	-16.3%	-47.4%
Enterprise value	€45.5M	€28.3M	€35.2M	€27.3M	€31.3M	€41.5M	€28.2M	€19.9M
Net debt / EBITDA	2.75×	-27.96×	17.49×	-3.72×	-32.05×	-72.16×	-8.53×	-2.21×
Cash conversion cycle (days)	108	117	145	137	147	176	89	154